Modifying Duties Addressing the Synthetic Opioid Supply Chain in the People's Republic of China
1. Purpose
Executive Order 14357 aims to modify tariffs on select articles from the People's Republic of China to address the national emergency posed by synthetic opioids, particularly fentanyl, while reflecting China's commitment to mitigate this issue.
2. Key Actions And Directives
- Modify Tariffs: Reduce the additional ad valorem duty rate from 20% to 10% on certain articles from China, effective November 10, 2025.
- Monitor Commitments: The Secretary of Homeland Security is tasked with overseeing the implementation of PRC's commitments to curb synthetic opioid shipments.
- HTSUS Modifications: The Secretary of Homeland Security shall work with the U.S. International Trade Commission to amend the Harmonized Tariff Schedule of the United States as necessary.
3. Important Points
- PRC's Commitment: China has committed to taking significant actions to reduce the flow of synthetic opioids, which prompted these tariff modifications.
- Consequences of Non-compliance: Failure by the PRC to adhere to its commitments could result in the President revising the Executive Order to address the emerging national emergency.
- Severability Clause: If any part of the Executive Order is found invalid, the remaining provisions will continue in effect, ensuring the Order's integrity.
- Legal Authority: The President's actions are supported by the International Emergency Economic Powers Act and the National Emergencies Act, granting authority to respond to national emergencies.
Disclaimer: ExecBrief's are AI generated, Please verify with the original source to confirm
Click here to provide feedback to help us improve your experience!
Comments